RGEN insiders

16 insiders have filed at RGEN since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Dawes Karen ADirector91.8k0.162%3 sells $383k
Hunt AnthonyDirector89.1k0.157%1 buys $248k48 sells $31.2M
Loeillot OlivierChief Executive Officer58.1k0.102%1 sells $1.2M
Muir Glenn PDirector36.6k0.065%
Gebski ChristineSee Remarks27.4k0.048%1 sells $557k
Bylund JamesChief Operating Officer25.4k0.045%2 sells $1.2M
Garland Jason KCFO20.1k0.035%
Kuriyel RalfSenior VP, R&d20.1k0.035%4 sells $2.6M
Douglass Brian RobbChief Product Officer8.3k0.015%
Madaus Martin DDirector7.4k0.013%3 buys $404k
Eglinton Manner CarrieDirector4.5k<0.01%
Barthelemy NicolasDirector4.4k<0.01%1 buys $151k
Hughes ViolettaChief Accounting Officer4.1k<0.01%
Mhatre RohinDirector4.0k<0.01%
Konstantinov KonstantinDirector2.9k<0.01%
Pax MargaretDirector2.0k<0.01%1 buys $38k

Full register at boothcheck.com/insiders/RGEN. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

RGEN institutional holders · RGEN research report